GORKA
LARRINAGA EMBEITA
PROFESORADO PLENO
Hospital Universitario de Getafe
Getafe, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario de Getafe (10)
2024
-
Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients
International Journal of Molecular Sciences, Vol. 25, Núm. 13
-
The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy
International Journal of Molecular Sciences, Vol. 25, Núm. 3
2021
-
(Pro)renin receptor is a novel independent prognostic marker in invasive urothelial carcinoma of the bladder
Cancers, Vol. 13, Núm. 22
-
Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma
Cancers, Vol. 13, Núm. 4, pp. 1-17
2020
-
Altered tissue and plasma levels of fibroblast activation protein-α (FAP) in renal tumours
Cancers, Vol. 12, Núm. 11, pp. 1-16
2019
2018
-
High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma
Annals of Diagnostic Pathology, Vol. 34, pp. 27-30
2016
-
Low-grade metastases in high-grade clear cell renal cell carcinomas A clinicopathologic study of 4 cases with an insight into the role of mesenchymal-to-epithelial transition process
Annals of Diagnostic Pathology, Vol. 20, pp. 13-18
-
The expression of fibroblast activation protein in clear cell renal cell carcinomas is associated with synchronous lymph node metastases
PLoS ONE, Vol. 11, Núm. 12
2015
-
The normal and pathologic renal medulla: A comprehensive overview
Pathology Research and Practice, Vol. 211, Núm. 4, pp. 271-280